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Abstract
Background: Docosahexaenoic acid (DHA), an omega-3 fatty acid found in breast milk, has many health benefits
for both mother and baby. A 2007 meta-analysis found U.S. women had breast milk DHA levels (0.20% of total fatty
acids) below the worldwide mean (0.32%). In 2008, international dietary recommendations were made for pregnant
and lactating women to consume 200 mg of DHA per day. This community-based study aimed to define current
milk DHA levels from upper Midwest USA lactating mothers and to determine if providing information about their
own level along with dietary recommendations would incite changes to increase breast milk DHA content.
Methods: New mothers attending lactation classes or using hospital pumping rooms in Sioux Falls, South Dakota,
USA participated by providing one drop of breast milk on a card for fatty acid analysis at baseline and 1 month
after initial reporting. DHA levels were analyzed by gas chromatography. Mothers received a report of their own
breast milk level along with dietary recommendations on DHA intake for lactating women. Median baseline and
follow-up DHA levels were determined and differences were compared by Wilcoxon signed-rank test.
Results: At baseline, breast milk DHA content (n = 84) was highly variable (range 0.05 to 0.73%) with a median of 0.18%
(IQR, 0.13, 0.28; mean ± SD, 0.22 ± 0.13%), well below the worldwide average (0.32%). Women who reported taking DHA
supplements (n = 43) had higher levels than those who did not (0.23% vs. 0.15%, P < 0.0001). In a subset of 60 mothers
who submitted a second sample, median breast milk DHA content increased from 0.19 to 0.22% (P < 0.01).
Conclusions: Findings suggest that providing nursing mothers with their breast milk DHA level and education about
DHA intake while breastfeeding motivates change to increase DHA levels.
Keywords: Breast milk fatty acids, Docosahexaenoic acid, Omega-3 fatty acids, Long chain polyunsaturated fatty acids,
Breastfeeding
Background
Long-chain polyunsaturated fatty acids (LCPUFAs) are es-
sential nutrients required for normal health, growth and
development. Of these, arachidonic acid (ARA, an omega-6
fatty acid) and docosahexaenoic acid (DHA, an omega-3
fatty acid) are especially important for the health of both
mother and the developing infant who relies on provision
from breast milk or formula. Mother’s milk is the best
nutrition for babies in the first 6 months of life and it con-
tains all the essential LCPUFAs. Although breast milk levels
of ARA are fairly stable, breast milk levels of DHA are
largely determined by maternal blood levels and influenced
by intake, whether from fish (which can vary markedly
around the world) or DHA supplementation (e.g., omega-3
or fish oil supplements) [1, 2]. DHA has important health
benefits for pregnant and lactating mothers and increasing
evidence shows that infants fed breast milk with a higher
DHA content have better vision and neurodevelopmental
outcomes [3–9].
A meta-analysis based on studies published between
1986 and 2006 reported that the estimated worldwide
average (WWA) level of DHA in human milk was a mean
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of 0.32 ± 0.22% with a wide range of 0.06 to 1.4% of total
fatty acids [10]. Since 2007, this value has been adopted by
many infant formula companies as a target for DHA con-
tent in their products. The assumption that the WWA
should be considered the target has been both questioned
[11] and supported [4]. On average women in the US have
breast milk DHA levels below this reported WWA. Based
on ten studies completed before 2007 (mean n per
study = 23), the average breast milk DHA level in US
mothers was 0.19% (Table 1). In seven US studies pub-
lished after 2007 (six studies with mean n = 38 and one
study with a sample n = 287), the average breast milk
DHA level was still below the WWA at 0.17%.
The apparent lack of change in breast milk DHA levels in
the US may be due to conflicting advice regarding recom-
mended DHA intake and the safety of fish consumption
during pregnancy and lactation. In the early 2000s, recom-
mendations were made by the US Food and Drug Adminis-
tration that pregnant and lactating women should limit
their intake of fish that could contain high levels of methyl-
mercury [12], which was followed by a decline in fish con-
sumption by pregnant women [13]. In 2008, international
recommendations were made for pregnant and lactating
women to consume 200 mg of DHA per day, ideally from
low mercury fish [14]. These seemingly conflicting recom-
mendations may have inadvertently led to a decrease in
DHA intake in lactating women. This is evidenced by the
observation that breast milk DHA levels have not increased
since the 2008 recommendation.
There is an ongoing need for up-to-date information on
what “normal” human milk DHA levels are for American
women and how women can safely increase them. Ac-
cordingly, the objective of this study was to determine
what current breast milk DHA levels are in lactating
women in the upper Midwest USA (a region not previ-
ously examined). The second goal of this study was to ex-
plore whether informing mothers of their own milk’s
DHA along with dietary recommendations would incite
changes to increase breast milk DHA.
Methods
Recruitment
Participants were recruited from breastfeeding classes,
community breastfeeding support groups and pumping
Table 1 Overview of studies of breast milk DHA before and after a 2007 review [10]
Reference Site Participants DHA (% wt)
Studies published before 2007
Harris et al., 1984 [47] Oregon, US 8 0.10%
Carlson et al., 1986 [48] US 11 0.19%
Henderson et al., 1992 [29] Connecticut, US 5 0.37%
Francois et al., 1998 [49] Oregon, US 14 0.20%
Jensen et al., 2000 [1] US 24 0.24%
Auestad et al., 2001 [50] US 43 0.12%
Francois et al., 2003 [37] Oregon, US 7 0.20%
Bopp et al., 2005 [51] North Carolina, US 22 0.21%
Jensen et al., 2005 [6] Texas, US 77 0.20%
Yuhas et al., 2006 [52] US 49 0.17%
Average a 260 0.19%
Studies published after 2007
Glew et al., 2008 [53] New Mexico, US 29 0.11%
Valentine et al., 2010 [54] Ohio, US 39 0.10%
Glew et al., 2011 [55] New Mexico, US (American Indian) 19 0.10%
Baack et al., 2012 [56] Iowa, US 31 0.07%
Texas, US 5 0.20%
North Carolina, US 5 0.15%
California, US 5 0.14%
Keim et al., 2012 [57] North Carolina, US 287 0.20%
Valentine et al., 2013 [58] Ohio, US 13 0.18%
Sherry et al., 2015 [36] US 82 0.18%
Average a 515 0.17%
aWeighted mean by study n
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rooms at Sanford Health in Sioux Falls, South Dakota,
USA via displayed materials and available study packets
that explained the eligibility criteria. Study packets in-
cluded an invitation letter, a consent form, two sample
collection cards (baseline and 1 month with instructions
for use), two brief questionnaires (baseline and 1 month),
and two pre-paid, return mail envelopes (baseline and 1
month). Women over 18 years of age, lactating for at least
1 week, planning to breastfeed for at least an additional 4
weeks, and able to read English were included in the
study. Women who met the inclusion criteria were en-
rolled when they voluntarily returned a signed informed
consent, a dried mother’s milk sample, and a completed
baseline questionnaire.
Fatty acid analysis
One drop of breast milk was placed on a filter paper col-
lection card [15] and mailed to the laboratory (Omega-
Quant Analytics, LLC; Sioux Falls, SD) for measurement
of fatty acid content. Fatty acids were determined using
gas chromatography and levels are presented as a percent
of total fatty acids as previously described and validated
[16]. In short, dried breast milk samples were combined
with the methylating mixture [boron trifluoride in metha-
nol (14%), toluene and methanol (35/30/35 v/v)], shaken
and heated at 100 °C for 45 min. After cooling, equal vol-
umes of hexane and distilled water were added. Samples
were briefly vortexed, spun to separate layers, and an ali-
quot of the hexane (upper) layer which contained the fatty
acid methyl esters was taken for analysis by gas chroma-
tography as described previously [17].
Feedback and follow-up
Participants received their baseline breast milk DHA
level and dietary recommendations via an emailed report
within 1 week of sending in their sample. The report
gave different instructions to the mother depending on
her DHA level. If her level was below the WWA (0.32%
DHA), she was advised to increase her DHA intake via
low-mercury containing fish and/or a DHA supplement
(with a target of 200 mg DHA/day as recommended
[14]). To assist with this, a table showing the DHA and
mercury content of a variety of seafood and supplements
was included with the report (Additional file 1; Fish in-
take). If her breast milk DHA level was at or above the
WWA, she was encouraged to maintain her current
level of DHA intake. A second breast milk sample was
collected and returned with another brief questionnaire
4 weeks after the first sample was taken.
Survey collection
Although simple, the questionnaires were designed to
determine what changes, if any, had been made to fish
intake and/or the use of DHA supplements in response
to the information provided with the first DHA value
(Additional files 2 and 3). One-page surveys were volun-
tarily filled out and returned by participants in pre-paid,
return mail envelopes. The baseline survey collected infor-
mation about demographic and pregnancy characteristics,
average servings of fish per month and the use of a DHA
containing supplement (Additional file 2; Baseline question-
naire). The follow-up survey simply asked if the first
mother’s milk DHA test motivated change in diet or sup-
plementation (Additional file 3; Follow-up questionnaire).
Statistical analysis
Data are presented as medians (Interquartile Range [IQR];
25th percentile, 75th percentile) due to the non-normal
distribution for most variables. Categorical variables, i.e.
race/ethnicity in all participants versus those participants
who provided a follow-up sample, were compared using
Fisher’s Exact test. Mann-Whitney test was used to com-
pare baseline continuous variables, including DHA levels,
between independent groups. Wilcoxon signed-rank test
was used to compare the difference between baseline and
follow-up DHA levels in participants who provided a
follow-up sample after being informed of their initial
DHA level. Significance was set at P < 0.05. Data were an-
alyzed using GraphPad Prism 6 (GraphPad software, San
Diego, CA, US).
Results
Baseline data were available from 84 women. Of them,
20 did not return their follow-up sample and question-
naire (Fig. 1). For six women, email difficulties prevented
them from receiving their baseline breast milk DHA re-
sults (apparently due to spam email filters). Four of these
six women still sent in their follow-up sample despite
not receiving their baseline report, but this data was not
used in the main analyses as they were unable to make
an informed decision about whether to change their
DHA intakes without baseline information. The reasons
why the other 20 mothers (including two who did not
Fig. 1 Diagram of study design and participant flow
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receive their baseline results) did not send follow up
samples are unknown. Therefore, 60 women were in-
cluded in the follow-up analyses.
Participants who provided a follow-up sample included
71% of all participants and there was no statistically sig-
nificant differences in baseline characteristics between
women who provided follow-up sample and those who
did not (Table 2). On average, the women who provided
baseline breast milk samples were 30 years old, had a
pre-pregnancy BMI of 24 kg/m2, had two children, were
white/Caucasian, and were relatively highly educated.
There were no statistically significant baseline differ-
ences between the cohort of women who provided the
follow-up data (n = 60) and those not included in the
follow-up analysis (n = 24); however, there was weak evi-
dence for a difference in pre-pregnancy BMI (P = 0.055).
Mother’s milk fatty acid profiles are reported in Table 3.
Baseline breast milk DHA levels from mothers in our
study (from the upper Midwest USA) were highly variable
(range 0.05 to 0.73%) with a median value of 0.18% (IQR:
0.13, 0.29; mean ± SD, 0.22 ± 0.13%) which is below the
WWA (0.32%), but consistent with previous studies in
North American women (see Table 1). The referenced
WWA10 included data from non-supplementing women;
to understand how non-supplementing women in the
upper Midwest USA compare, the average mother’s milk
DHA level of the non-supplementing women in our base-
line cohort (n = 43/84, 51%) was also calculated. The me-
dian mother’s milk DHA level for non-supplementing
women was 0.15% (IQR: 0.11, 0.19) which is significantly
lower than the WWA and also significantly lower than
those women in our study who reported taking a supple-
ment (IQR: 0.15% vs. 0.23%, P < 0.0001; Fig. 2). Women
who reported taking a DHA supplement during their last
trimester of pregnancy (n = 59/84, 70%) also had higher
breast milk DHA levels than those who did not report this
(0.19% vs. 0.14%, P < 0.01). Only 14 women in our study
had baseline breast milk DHA levels greater than the
WWA. Of them, 13 reported taking a DHA supplement.
Despite this, 42% (n = 30/70) of women whose baseline
breast milk DHA level was below the WWA reported tak-
ing a DHA-containing supplement. This suggests that the
routine supplementation reported was not adequate to
raise mother’s milk levels to the WWA.
In our study, the reported intake of fish did not correl-
ate with mother’s milk DHA levels: “Less than 1 serving/
month” 0.18% (IQR: 0.14, 0.24; n = 24); “1 to 3 servings/
month” 0.18% (IQR: 0.11, 0.31; n = 47); “4 or more serv-
ings/month” 0.18% (IQR: 0.15, 0.30; n = 13).
Follow-up samples (n= 60) were collected 38 ± 17 days
after the baseline sample. Median mother’s milk DHA levels
increased significantly from baseline in this cohort (0.19 to
0.22%, P < 0.01; Fig. 3). Whether women had baseline breast
milk DHA levels higher (n = 11) or lower (n = 49) than the
WWA did not affect the magnitude of the change in DHA
levels (−0.03% vs. +0.04%, respectively; P = 0.40. Forty-three
of 60 women in the follow-up cohort responded to ques-
tions about the extent to which receiving information on
their breast milk DHA levels motivated them to make diet-
ary and/or supplementation changes. Of them, 51% (n = 22/
43) reported changing their diet and 57% (n = 25/43) re-
ported changing their supplementation habits.
Discussion
There were two primary findings of this study. First,
mother’s milk DHA levels in the Midwestern community
of Sioux Falls, SD, USA averaged about 0.22%, which
correlates with other North American studies, but is well
below the WWA of 0.32%. This finding is disconcerting
given 2007 guidelines to increase DHA provision during
pregnancy and lactation for the health of both mother
and her baby [14]. Although most women in our cohort
reported eating fish, mother’s milk DHA levels did not
Table 2 Baseline characteristics and DHA levels of study participants




Age (years) 30 (27, 32) 30 (27, 32)
Pre-pregnancy BMI (kg/m2) 24.2 (21.7, 28.1) 23.6 (21.1, 26.6)
Race/Ethnicity (% White/
Caucasian)
99% (83) 98% (59)
Education (Associates
Degree or more)
87% (73) 85% (51)
Parity (number of
pregnancies)
2 (1, 3) 2 (1, 3)
Gestation length (weeks) 39 (38, 40) 39 (38, 40)
Lactation length (weeks) 15.3 (6.0, 28.8) 12.0 (6.0, 22.8)
Pregnancy weight gain (kg) 15.9 (13.6, 22.7) 15.9 (13.6, 23.8)
Percent of mothers who
had diabetes during
pregnancy (n)
7% (6) 7% (4)
Percent of mothers
supplementing
with DHA during lactation
(baseline; n)
51% (43) 53% (32)
Percent of mothers who
supplemented with DHA
during pregnancy (n)
72% (59) 71% (42)
Breast milk DHA level
(% of total fatty acids)
0.18% (0.13, 0.28) 0.19% (0.15, 0.30)
Percent of mothers with milk
DHA≥ 0.32% (Worldwide
Average b; n)
17% (14) 18% (11)
DHA docosahexaenoic acid, BMI body mass index
aAll variables except for breast milk DHA levels were from self-reported data
collected at baseline. Medians and interquartile ranges (IQR) presented and
compared using Mann-Whitney (continuous) and Fisher’s Exact (categorical)
statistical tests. No differences between groups were detected
bWorldwide average as estimated by Brenna et al. [10]
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correlate with fish intake. Reporting the use of a DHA
supplement did correlate with mother’s milk DHA levels
in our study. In this upper Midwestern USA cohort, 46%
of the women reported taking a DHA supplement, and
yet their average breast milk DHA level was still one-
third lower than the WWA. Women who reported not
taking a DHA supplement during lactation had even
lower breast milk DHA levels, at about 50% of the
WWA. Although compliance was not monitored in this
study, findings suggest that routine guidelines for DHA
supplementation during lactation may not be enough to
increase mother’s milk DHA levels to the WWA.
The second finding of this study is that when women
were provided with information about their breast milk




(n = 84) 1
Participants who provided a follow-up sample (n = 60)1 P-value 2
Baseline 4 weeks
N6:N3 12.10 (10.28, 13.88) 11.65 (9.70, 13.85) 11.10 (9.43, 12.65) 0.10
AA:EPA 9.61 (5.82, 12.66) 9.57 (5.52, 13.95) 6.63 (3.52, 10.74) 0.0008*
SAT 33.35% (29.73, 35.68) 33.50% (30.08, 35.60) 33.50% (31.13, 37.03) 0.06
MUFA 36.65% (34.13, 39.93) 37.25% (35.63,41.78) 36.80% (34.00, 39.90) 0.32
N6 18.80% (16.33, 21.88) 18.65% (16.75, 22.48) 18.60% (15.30, 21.75) 0.11
N3 1.60% (1.30, 1.98) 1.60% (1.33, 2.18) 1.60% (1.40, 2.10) 0.91
TRANS 1.70% (1.30, 2.20) 1.65% (1.20, 2.20) 1.75% (1.40, 2.28) 0.42
C10:0 1.00% (0.80, 1.38) 1.10% (0.90, 1.48) 1.10% (0.90, 1.30) 0.51
C12:0 5.10% (3.43, 6.60) 5.50% (3.43, 6.90) 5.30% (4.00, 6.98) 0.05
C14:0 5.65% (4.20, 6.98) 6.00% (4.25, 7.55) 5.90% (4.40, 7.30) 0.03
C16:0 20.55% (19.20, 22.18) 20.10% (19.03, 22.43) 20.20% (18.88, 22.45) 0.49
C16:1n7t 0.10% (0.10, 0.10) 0.10% (0.10, 0.10) 0.10% (0.10, 0.10) >0.99
C16:1n7 1.75% (1.30, 2.38) 1.85% (1.40, 2.50) 1.80% (1.43, 2.10) 0.97
C18:0 6.35% (5.43, 7.20) 6.35% (5.50, 7.10) 6.80% (5.90, 7.88) 0.04
C18:1 t 1.20% (0.90, 1.70) 1.20% (0.90, 1.70) 1.30% (1.00, 1.70) 0.41
C18:1n9 34.75% (32.25, 38.08) 34.90% (32.70, 39.78) 34.25% (31.78, 37.13) 0.29
C18:2n6tt 0.40% (0.30, 0.40) 0.30% (0.30, 0.40) 0.30% (0.30, 0.40) 0.70
C18:2n6 17.45% (15.30, 20.83) 16.90% (15.30, 20.98) 17.30% (14.10, 20.03) 0.13
C20:0 0.20% (0.20, 0.20) 0.20% (0.20, 0.20) 0.20% (0.20, 0.20) 0.57
C18:3n6 0.20% (0.10, 0.20) 0.20% (0.10, 0.20) 0.20% (0.10, 0.20) 0.13
C20:1n9 0.30% (0.30, 0.40) 0.30% (0.30, 0.40) 0.30% (0.30, 0.40) 0.81
C18:3n3 1.20% (0.90, 1.50) 1.20% (0.90, 1.68) 1.10% (1.00, 1.40) 0.47
C20:2n6 0.30% (0.30, 0.40) 0.30% (0.30, 0.40) 0.30% (0.20, 0.30) 0.003*
C22:0 0.10% (0.10, 0.10) 0.10% (0.10, 0.10) 0.10% (0.10, 0.10) 0.29
C20:3n6 0.35% (0.30, 0.40) 0.40% (0.30, 0.50) 0.30% (0.30, 0.40) <0.0001*
C20:4n6 0.45% (0.40, 0.50) 0.50% (0.40, 0.50) 0.40% (0.40, 0.50) 0.01*
C24:0 0.10% (0.00, 0.10) 0.10% (0.00, 0.10) 0.10% (0.00, 0.10) 0.73
C20:5n3 0.00% (0.00, 0.10) 0.00% (0.00, 0.10) 0.10% (0.10, 0.10) 0.004*
C24:1n9 0.00% (0.00, 0.00) 0.00% (0.00, 0.00) 0.00% (0.00, 0.00) 0.48
C22:4n6 0.10% (0.10, 0.10) 0.10% (0.10, 0.10) 0.10% (0.10, 0.10) 0.09
C22:5n6 0.00% (0.00, 0.00) 0.00% (0.00, 0.00) 0.00% (0.00, 0.00) >0.99
C22:5n3 0.10% (0.10, 0.20) 0.10% (0.10, 0.20) 0.10% (0.10, 0.20) 0.19
C22:6n3 0.18% (0.13, 0.29) 0.19% (0.14, 0.30) 0.22% (0.16, 0.35) 0.007*
Abbreviations: N6:N3 omega-6:omega-3 fatty acid ratio, AA:EPA arachidonic acid: eicosapentaenoic acid ratio, SAT total saturated fatty acids, MUFA total monounsaturated
fatty acids, N6 total omega-6 fatty acids, N-3 total omega-3 fatty acids, TRANS total trans fatty acids
1 Medians (IQR)
2 Significance was set at P ≤ 0.01* (due to multiple variables) comparing the baseline and follow-up samples from participants who provided a follow-up sample
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DHA levels and information on the recommended in-
take for lactating mothers, they responded with a mod-
est increase in milk DHA content within about 1 month.
This suggests that mother’s milk DHA testing, alongside
written educational information, may be an efficient and
cost effective approach to motivate lactating women to
improve their DHA status and in turn, that of their
nursing infant.
DHA, an omega-3 LCPUFA, is an essential nutrient
important for both maternal and infant health [5, 18].
For the pregnant woman, DHA status is directly associ-
ated with the length of gestation [19] and fetal growth
[20] and is indirectly associated with anxiety [21] and
postpartum depressive symptoms [5]. Indeed, supplemen-
tation during pregnancy may even decrease healthcare
costs [22]. The developing baby receives LCPUFAs pri-
marily from a maternal source and mother’s blood and
milk DHA levels directly correlate with DHA levels in in-
fants [2]. For the baby, DHA supports vision, brain devel-
opment, memory [23], attention [24] and immunological
status [25]. Indeed, improved DHA status during infancy
may have lasting effects on learning [26] and is associated
with less atopic disease [5, 25].
Human milk contains all essential LCPUFAs, but unfor-
tunately, DHA levels are extremely variable and dependent
on maternal intake [9, 10]. There are very few outcomes
based studies conducted in infants who are exclusively
breastfed with varying levels of DHA when compared to
studies conducted in infants who are fed formula with
varying DHA content. Thus, the optimal breast milk DHA
level has yet to be determined. There is evidence to sug-
gest that breast milk DHA levels of 0.32% or greater con-
fers added benefit for the infant’s neurodevelopment as
compared to lower DHA values (~0.2%), which are typical
of US mothers [2, 4, 6, 27]. Unfortunately, in the WWA
report [10], the coefficient of variability across populations
for DHA was 69% whereas that for ARA was only 28%.
This variability in DHA levels is based on many factors, in-
cluding maternal age [28], genetic variation, race, gesta-
tion, body mass index, parity, smoking, duration of
lactation, and most importantly, maternal diet [1, 29–35].
Maternal consumption of an appropriate ratio of ω-3 and
ω-6 fatty acids and adequate preformed DHA intake dir-
ectly correlate with breast milk DHA levels [9, 36]. In-
creasing intake of alpha-linolenic acid, the plant-based
precursor to DHA, does not significantly increase breast
milk DHA levels [37]. Therefore, a minimum daily DHA
intake of 200 mg/day is recommended for pregnant and
lactating women to support both maternal and infant
health [14, 38].
It has been clearly shown that supplementation in-
creases mother’s milk DHA content [25, 33, 39]. Unfortu-
nately, in our study women who report taking a DHA
supplement still had breast milk DHA levels below the
WWA. Although compliance and average daily DHA
doses were asked for from our study participants, these
specific response rates were low making it difficult to draw
any insight about optimal supplementation doses. Simi-
larly, formal dietary assessment was not conducted in this
study, so background dietary intake of DHA cannot
be ascertained. According to the 2009–2010 National
Health And Nutrition Survey (NHANES), women 20–
39 years of age have an average DHA intake only 50–
60 mg/day [40]. By comparison, DHA intake in
Fig. 2 Baseline mother’s milk DHA levels. Comparison of baseline milk
DHA levels between women who reported taking DHA supplements
(0.23%, IQR 0.17, 0.34; n = 43) and those who did not (0.15%, IQR 0.11,
0.19; n = 41) during lactation. Group medians compared with Mann-
Whitney statistical test. Symbols (dots) represent individual participant
data, bar represents median, lines represent IQR. Worldwide average
breast milk DHA level from Brenna et al [10] is indicated by the
dashed line
Fig. 3 Mother’s Milk DHA Levels from Participants who Provided
Follow-up. Milk DHA levels at baseline (0.19%, IQR, 0.14, 0.30) and at
least 4 weeks later (0.22%, IQR, 0.16, 0.35) from participants who
provided follow-up (n = 60). Group medians compared with the
Wilcoxon statistical test. Symbols (dots) represent individual participant
data, bar represents median, lines represent IQR. Worldwide average
breast milk DHA level from Brenna et al. [10] indicated by a dashed line
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pregnant women in Japan is over 300 mg/day [41]
and the three Japanese studies reported in the meta-
analysis by Brenna et al. [10] had breast milk DHA
levels of 0.53, 0.99 and 1.1%. Even women in parts of
the world where fish intake is not as high as it is in
Japan have higher mother’s milk DHA levels than the
women in our study [33, 42, 43]. Moreover, others
have found that using a higher daily dose of DHA
during pregnancy and lactation is safe (≥800 mg/day
[44]), increases both maternal and infant levels and
may provide additional health benefits [9].
Although mother’s milk DHA levels in our study were
lower than the WWA, we observed that a majority of
women who were informed about their breast milk DHA
level and given information about how to safely increase it
were motivated to do so. This was evidenced by their re-
sponses to questions about changes made to diets or sup-
plementation habits and by a significant increase in
mother’s milk DHA levels 5–6 weeks later. Since DHA
levels in mature milk typically remain the same or decline
over time [30, 33, 34], we believe the observed increase
was due to increased nutritional DHA intake (primarily
from supplements) and not to other biological factors.
Other influences associated with maternal DHA status
such as race, gestation, and body weight [33, 45, 46] did
not change within our study population. Because in-
creased DHA status is associated with positive maternal
and neonatal outcomes, and the guidelines alone have not
changed mother’s milk DHA levels, we recommend that
breastfeeding mothers should be routinely counseled
about the benefits of supplementing DHA during lactation
[14]. We also concur that testing and informing mothers
about their breast milk DHA levels could be a novel and
cost-effective way to improve DHA status and would pro-
vide measurable values necessary to guide ongoing adjust-
ment in the recommended daily dose of DHA during
pregnancy and lactation to optimize outcomes for both
mother and baby.
Limitations and advantages
A limitation of this study was that the cohort was racially
homogeneous and relatively well-educated, which un-
doubtedly introduced some selection bias. Regardless,
mother’s milk DHA levels still were generally low. All
mothers in this study lived in the upper Midwest of the
USA and in a single community (a review of past studies
[Table 1] suggests that single city studies are the norm in
this research arena). Since there is little data in the litera-
ture on milk FA status from women in this region, this
study fills a gap in knowledge and helps us understand the
community’s response to routine recommendations
and additional counseling of lactating mothers. An-
other limitation is that follow up was not complete in
all participants. Several mothers did not return a
second test within a month of getting the report on
their breast milk DHA levels. Accordingly, we cannot
properly determine the extent to which providing this
education motivated change since the group of
women who did send a second sample may not be
representative of all women in the study. However,
baseline characteristics of those who did and did not
submit a follow up sample were similar.
An additional study limitation was our dependence on
self-report for demographic, dietary and supplement use
information. The questionnaire was simple and did not in-
clude a validated food diary or the timing of sample collec-
tion during the feed (before, during or after a breastfeed).
The use of a validated food diary would provide valuable
information about maternal diet, but may have hindered
participation and compliance. While timing of sample col-
lection affects the measured total fat content of milk, it
should not affect the percent composition of fatty acids in
mother’s milk which was used in this study. Possible mis-
understandings of certain items in the baseline question-
naire (e.g., parity, duration of lactation, etc.) and failing to
complete the entire survey could have been avoided with a
real-time interview; however, this type of interaction may
have introduced persuasion bias. Additionally, there was
no control group that did not receive feedback on their
breast milk DHA levels, and so we cannot strictly attribute
the changes in dietary/supplementation behavior and
breast milk DHA levels to the feedback and education
provided.
Strengths of the study include that it is a relatively large
sample size (for this type of project) being the second lar-
gest of the 17 studies included in Table 1. This is the only
study to our knowledge that explores the effects of inform-
ing the subjects of their own personal levels on breast milk
DHA levels. We also used a novel and validated dried milk
spot method to collect and measure milk DHA content.
The test is simple to use, with little to no risk and is com-
mercially available; whether the cost outweighs the benefit
remains to be seen.
Conclusions
Despite current guidelines aimed to support DHA status
during pregnancy and lactation, breastfeeding mothers
in this upper Midwestern USA city have mother’s milk
DHA levels that are lower than the WWA, even with re-
ported fish or supplement intake. However, breast milk
DHA content can be increased with personalized testing
and the provision of information about safe ways to at-
tain the recommended daily DHA intake during lacta-
tion. Offering mother’s milk DHA testing and further
education about the importance of DHA during lacta-
tion may advance the understanding of optimal
provision for breastfeeding mothers and improve health
outcomes for mothers and their babies.
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